Share Name Share Symbol Market Type Share ISIN Share Description
Horizon Discvry LSE:HZD London Ordinary Share GB00BK8FL363 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.00p -0.92% 216.50p 213.00p 220.00p 218.50p 216.50p 218.50p 36,295 14:57:01
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 20.2 -10.5 -11.2 - 208.81

Horizon Discvry (HZD) Latest News

More Horizon Discvry News
Horizon Discvry Takeover Rumours

Horizon Discvry (HZD) Share Charts

1 Year Horizon Discvry Chart

1 Year Horizon Discvry Chart

1 Month Horizon Discvry Chart

1 Month Horizon Discvry Chart

Intraday Horizon Discvry Chart

Intraday Horizon Discvry Chart

Horizon Discvry (HZD) Discussions and Chat

Horizon Discvry Forums and Chat

Date Time Title Posts
23/5/201711:49Horizon Discovery Ltd - Genomic translation 819
23/7/201415:43Alan Green says to BUY and HOLD in Horizon-

Add a New Thread

Horizon Discvry (HZD) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Horizon Discvry trades in real-time

Horizon Discvry (HZD) Top Chat Posts

Horizon Discvry Daily Update: Horizon Discvry is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker HZD. The last closing price for Horizon Discvry was 218.50p.
Horizon Discvry has a 4 week average price of 201p and a 12 week average price of 160p.
The 1 year high share price is 218.50p while the 1 year low share price is currently 105p.
There are currently 96,445,840 shares in issue and the average daily traded volume is 207,855 shares. The market capitalisation of Horizon Discvry is £208,805,243.60.
mamcw: A no news share price rise is always most intriguing. Long may this last!
catswhiskas: Looks like we've had a few sellers around recently which accounts for the weak share price hopefully the overhang will clear and we can move up anyone know if there's news due ?
catswhiskas: Will the share price ever reach the Disley heights of £2 ever again ! Its broken into another down trend 145p looks possible again if there is no news which makes my recent top ups look extremely bad timing !Another AIM share cert for the bottom draw but hey nothing new there !!
pjj71: nearly a million shares traded and know share price movement!!!
kestelmill: I was on a long train journey on Friday so used the time to have a good look at all the reports and interims of HZD to work out what is going on here. These are my conclusions and thoughts. 1) The last interim gave revenue guidance of £24-26M but also said that revenues would be reduced by £2.7M in 2016 due to restructuring. This was effectively a profit warning - analysts were expecting more like £27-29M revenue and associated profit (loss) - and that is why the share price went down so much. 2) There is a restructuring process and an initiative to make £5M cost savings (£3M from closing down Boston). There is significant execution risk attached to this. 3) CEO has stated EBITDA will be positive in 2017. This reads as, EBITDA will be more than £0, but not by much. Analysts may well have been expecting more. 4) Even if positive EBITDA is achieved, there was £7.4M depreciation and amortisation in 2015. We can expect similar or higher figures every year for many years to come. This means HZD has to make >£8M EBITDA to truly break even on their P+L. Note there are £48M of Goodwill and intangible assets currently on the balance sheet; it looks like they are amortising over 10 years. 5) HZD has a strong technology licence position in gene editing but since the environment and, in particular, Crispr technology is still evolving and has an unclear IP situation, they may have to invest further in the future to protect their position. Also, they may have to, or decide to (since they are acquisitive), do further acquistions. This would create further complexity/risk. 6) There are clear current issues with service revenues. The stream of RNS telling us they have new business is reassuring - but these cannot be material to the revenue situation or they would have said so in the RNS. The company makes £20M revenues so you would expect some wins in the course of their ordinary business. On the other hand: a) they should be cash generative from 2017 b) these are growing markets and technologies which are yet to be fully realised c) they are very well positioned in gene editing and NGS d) there are potential additional upsides in the shape of Avvinity and the £200M+ of future royalties (although I am not putting any value on these at present) If HZD can grow revenues 25% for the next 3 years they will easily justify their current valuation. I believe they can do this so my overall conclusion is that this remains a good investment at the current share price
kestelmill: What more could they do on IR? They are posting good news every 5 mins. Hopefully it is simply that the IIs have decided they can't wait for HZD and have decided to get out, depressing the share price. I guess we will find out if something is afoot in due course.
kestelmill: Don't forget this share price should have been going up due to exchange rate benefits, having most sales in EUR and USD and repatriating to GBP. So actual share price performance has been even worse than it looks. You could be excused for wondering if some bad stuff is going on at the company that people like us aren't aware of. But actually the share price went down sharply on the latest report that service revenue had stalled and the company was still loss-making. I still believe the company is a decent product play and the service revenue issue could be a blip due to moving some of the capabilities to Cambridge from USA. Anyone close to the company got any insights?
kestelmill: HZD releases favourable news all the time, so we may have to wait a while for the market to love this stock. However, if the results are good the share price will rise. I believe HZD have a very compelling offering in a number of areas, not least NGS standards, and that the revenues will follow, and with it the rise in share price. Also as a startup that has grown rapidly there is no doubt loads of fat in this business that can be stripped out.
pjj71: not even the mega rally in US BIO has changed the share price fortunes!!! Come on HZD
nurdin: 'Horizon Discovery Group PLC with EPIC/TICKER LON:HZD has had its stock rating noted as ‘Retains’; with the recommendation being set at ‘BUY’ this morning by analysts at Panmure Gordon. Horizon Discovery Group PLC are listed in the Health Care sector within AIM. Panmure Gordon have set a target price of 270 GBX on its stock. This would indicate that the analyst believes there is a potential upside of 62.7% from the opening price of 166 GBX. Over the last 30 and 90 trading days the company share price has increased 13 points and increased 15.25 points respectively.' Nice.
Horizon Discvry share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:34 V: D:20170525 18:13:57